DIMO Healthcare Introduces ZEISS SLT revolutionising Glaucoma treatment in Sri Lanka

DIMOrecently announced the successful introduction of ZEISS Selective Laser Trabeculoplasty (SLT) technology through its healthcare arm, DIMO Healthcare. This groundbreaking laser treatment has revolutionized the management of glaucoma by effectively controlling the internal pressure of the eye through a single procedure, significantly reducing the need for daily medication in glaucoma patients.

The installation of the first ZEISS SLT at Mount Lotus Hospital marks a significant milestone in the field of ophthalmology in Sri Lanka. DIMO Healthcare, as the authorized local agent for ZEISS, remains committed to bringing advanced solutions to the country’s healthcare landscape. This treatment approach aligns with the recommendations of the National Institute for Health and Care Excellence (NICE) in the UK, which identifies SLT as the primary therapy for individuals newly diagnosed with chronic open-angle glaucoma.

Glaucoma, a prevalent eye condition, poses a global concern. ZEISS SLT offers a significant breakthrough by minimizing medication reliance for glaucoma patients, enhancing convenience, and optimizing treatment outcomes. Traditional glaucoma management often necessitates multiple daily medication administrations. However, the introduction of ZEISS SLT presents patients with a more streamlined and efficient treatment experience.